Zobrazeno 1 - 10
of 113
pro vyhledávání: '"K A, Foon"'
Publikováno v:
International Journal for Equity in Health, Vol 22, Iss 1, Pp 1-10 (2023)
Abstract Introduction Ensuring healthcare systems provide equitable, high quality care is critical to their users’ overall health and wellbeing. Typically, systems use various performance frameworks and related indicators to monitor and improve hea
Externí odkaz:
https://doaj.org/article/bbd3118db0404792b01f97a805c6dacd
Publikováno v:
Research Involvement and Engagement, Vol 9, Iss 1, Pp 1-5 (2023)
Abstract Globally, health systems are increasingly striving to deliver evidence based care that improves patients’, caregivers’ and communities’ health outcomes. To deliver this care, more systems are engaging these groups to help inform health
Externí odkaz:
https://doaj.org/article/16bddefaa1164473998bf28759079325
Autor:
K A Foon, Jennings Cd
Publikováno v:
Blood. 90:2863-2892
OVER A DECADE HAS passed since “Immunologic Classification of Leukemia and Lymphoma” by Foon and Todd was published in Blood .[1][1] Over this decade, flow cytometry has evolved from a promising new technology to an indispensable tool in the diag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9d818c36fe6816f802d734ea77200596
https://doi.org/10.1182/blood.v90.8.2863
https://doi.org/10.1182/blood.v90.8.2863
Autor:
Z. P. Bernstein, L. Vaickus, N. Friedman, M. H. Goldrosen, H. Watanabe, R. Rahman, S. G. Arbuck, J. Sweeney, D. Vesper, E. D. Henderson, J. Zeffren, R. A. Dennin, D. Levitt, K. A. Foon
Publikováno v:
Journal of Immunotherapy. 10:141-146
We conducted a phase II study utilizing interleukin-2 (IL-2) with lymphokine-activated killer (LAK) cells as therapy for non-Hodgkin's lymphoma (NHL) and Hodgkin's disease (HD). IL-2 was given at a fixed dose of 3 x 10(6) U/m2/day administered as a 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3269a3df0a39215363780d3e78d19e9a
https://doi.org/10.1097/00002371-199104000-00008
https://doi.org/10.1097/00002371-199104000-00008
Publikováno v:
Réanimation Urgences. 7:669-671
Resume La decouverte, lors d'un examen tomodensitometrique spirale thoracique, d'une hyperdensite au sein d'une image lacunaire intraluminale de l'artere pulmonaire a conduit a en rechercher l'origine. Les antecedents du patient et la comparaison ave
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4717541435c043d03032cdb427162cb5
https://doi.org/10.1016/s1164-6756(99)80070-x
https://doi.org/10.1016/s1164-6756(99)80070-x
Autor:
Mohamad A. Hussein, Sheila M. Dobin, Holly Gundacker, David H. Boldt, Shaker R. Dakhil, K A Foon, FR Appelbaum, David R. Head, G T Budd, Laurence Elias
Publikováno v:
Leukemia. 19(11)
B-cell chronic lymphocytic leukemia (CLL) accounts for 95% of chronic leukemia cases and 25% of all leukemia. Despite the prevalence of CLL, progress in its treatment has been only modest over the past three decades. Based upon the ability of fludara
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2e3bc19858bf162e9f3f2f1e1a9e0e1
https://pubmed.ncbi.nlm.nih.gov/16193091
https://pubmed.ncbi.nlm.nih.gov/16193091
Publikováno v:
Cancer chemotherapy and biological response modifiers. 19
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::682a80eae41b72f6f29b7a88b425c121
https://pubmed.ncbi.nlm.nih.gov/11686020
https://pubmed.ncbi.nlm.nih.gov/11686020
Autor:
K A, Foon, M, Bhattacharya-Chatterjee
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 7(5)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::988920f38226b82a7a03933d89f6e198
https://pubmed.ncbi.nlm.nih.gov/11350879
https://pubmed.ncbi.nlm.nih.gov/11350879
Publikováno v:
Current opinion in molecular therapeutics. 3(1)
Certain anti-idiotypic antibodies that bind to the antigen-combining sites of antibodies can effectively mimic the three-dimensional structures and functions of the external antigens and can be used as surrogate antigens for active specific immunothe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f156cfb35b77ea055c0e238c8c37c08c
https://pubmed.ncbi.nlm.nih.gov/11249733
https://pubmed.ncbi.nlm.nih.gov/11249733
Autor:
K A, Foon
Publikováno v:
Cancer journal (Sudbury, Mass.). 6(5)
Important advances in molecular biology and chelation chemistry have led to new and improved monoclonal antibody reagents. Rituximab (IDEC-C2B8) was approved by the United States Food and Drug Administration for relapsed CD20-positive lymphomas, and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9117822f0e5ecdd91116701ae1c836fe
https://pubmed.ncbi.nlm.nih.gov/11079163
https://pubmed.ncbi.nlm.nih.gov/11079163